Report: U.S. COPD Market - Therapeutic Overview and Patient Outlook

U.S. COPD Market - Therapeutic Overview and Patient Outlook

Published by

Frost & Sullivan

Published

2007/06

Content info

80 Pages

Product code

FS52899

Price

From US $ 6000

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Abstract

This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.